Logo

Log In Sign Up |  An official publication of: American College of Emergency Physicians
Navigation
  • Home
  • Multimedia
    • Podcasts
    • Videos
  • Clinical
    • Airway Managment
    • Case Reports
    • Critical Care
    • Guidelines
    • Imaging & Ultrasound
    • Pain & Palliative Care
    • Pediatrics
    • Resuscitation
    • Trauma & Injury
  • Career
    • Practice Management
      • Reimbursement & Coding
      • Legal
      • Operations
    • Awards
    • Certification
    • Early Career
    • Education
    • Leadership
    • Profiles
    • Retirement
    • Work-Life Balance
  • Compensation Reports
  • Columns
    • ACEP4U
    • Airway
    • Benchmarking
    • By the Numbers
    • EM Cases
    • End of the Rainbow
    • Equity Equation
    • FACEPs in the Crowd
    • Forensic Facts
    • From the College
    • Kids Korner
    • Medicolegal Mind
    • Opinion
      • Break Room
      • New Spin
      • Pro-Con
    • Pearls From EM Literature
    • Policy Rx
    • Practice Changers
    • Problem Solvers
    • Residency Spotlight
    • Resident Voice
    • Skeptics’ Guide to Emergency Medicine
    • Sound Advice
    • Special OPs
    • Toxicology Q&A
    • WorldTravelERs
  • Resources
    • mTBI Resource Center
    • ACEP.org
    • ACEP Knowledge Quiz
    • CME Now
    • Annual Scientific Assembly
      • ACEP14
      • ACEP15
      • ACEP16
      • ACEP17
      • ACEP18
      • ACEP19
    • Annals of Emergency Medicine
    • JACEP Open
    • Emergency Medicine Foundation
  • Issue Archives
  • Archives
    • Brief19
    • Coding Wizard
    • Images in EM
    • Care Team
    • Quality & Safety
  • About
    • Our Mission
    • Medical Editor in Chief
    • Editorial Advisory Board
    • Awards
    • Authors
    • Article Submission
    • Contact Us
    • Advertise
    • Subscribe
    • Privacy Policy
    • Copyright Information

Cardiovascular

  • Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients

    The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)...
  • Percutaneous Coronary Intervention Can Benefit Some at Age 90 and Older

    People in their nineties and older represent a tiny but growing fraction of patients who undergo percutaneous...
  • Fewer Admissions for Heart Failure, but Blacks Still Fare Worse than Whites

    Between 2002 and 2013, hospital admissions for heart failure fell by nearly a third in the U.S.,...

Results Confirm Idarucizumab’s Ability to Restore Clotting in Dabigatran Recipients

August 1, 2017 - Gene Emery (Reuters Health) - 0 Comment

The blood thinning effects of dabigatran (Pradaxa) can be quickly and reliably reversed by giving idarucizumab (Praxbind)…

Read More

Percutaneous Coronary Intervention Can Benefit Some at Age 90 and Older

July 25, 2017 - Anne Harding (Reuters Health) - 0 Comment

People in their nineties and older represent a tiny but growing fraction of patients who undergo percutaneous…

Read More

Fewer Admissions for Heart Failure, but Blacks Still Fare Worse than Whites

July 18, 2017 - Will Boggs, MD (Reuters Health) - 1 Comment

Between 2002 and 2013, hospital admissions for heart failure fell by nearly a third in the U.S.,…

Read More

Treatment Strategies for Shock-Resistant Ventricular Fibrillation

July 10, 2017 - Anton Helman, MD, CCFP(EM), FCFP - 0 Comment

The Case You get a call that a 50-year-old woman collapsed while running a marathon. Bystanders started…

Read More

Low Risk of Brain Hemorrhage in Ground-Level Fall with Antiplatelets, Anticoagulants

July 5, 2017 - Will Boggs, MD (Reuters Health) - 0 Comment

Patients who take antiplatelet or anticoagulant medications have a low risk of intracranial hemorrhage (ICH) associated with…

Read More

Prevalence of VTE in Syncope Patients Low; Routine Testing Unwarranted

May 23, 2017 - Megan Brooks (Reuters Health) - 0 Comment

Less than 2 percent of patients hospitalized with syncope have venous thromboembolism (VTE), hint results of a…

Read More

Coagulation Factor Concentrate Superior for Trauma-Induced Coagulopathy

May 22, 2017 - Reuters Staff - 0 Comment

Coagulation factor concentrates (CFC) are more effective than fresh frozen plasma (FFP) for reversing trauma-induced coagulopathy, according…

Read More

Increased Myocardial Infarction Risk Associated with NSAID Use

May 22, 2017 - Will Boggs, MD (Reuters Health) - 0 Comment

The use of oral nonsteroidal anti-inflammatory drugs (NSAIDs) is associated with an increased risk of acute myocardial…

Read More

Less-Aggressive Approach to Non-ST Segment Elevation Acute Coronary Syndromes Advised

May 16, 2017 - Scott Baltic (Reuters Health) - 0 Comment

Holding off on coronary angiography for patients with non-ST-segment elevation acute coronary syndromes (NSTE-ACS) and elevated cardiac…

Read More

HEART Score Safe for ED Evaluation of Chest Pain

May 9, 2017 - Will Boggs, MD (Reuters Health) - 1 Comment

NEW YORK (Reuters Health)—Use of the HEART score for evaluating patients with chest pain in the emergency…

Read More
  • ‹
  • 1
  • 2
  • 3
  • 4
  • ›
  • »

Current Issue

ACEP Now: February 2026 (Digital)

Read More

Wiley
  • Home
  • About Us
  • Contact Us
  • Privacy
  • Terms of Use
  • Advertise
  • Cookie Preferences
Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 2333-2603